Delivery Order SPE2DB20D2104-SPE2DB24FU29B
Award Date
5/20/24
Potential Completion Date
5/21/24
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens, a medication used for diabetes management, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $19,875.89, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA, valued...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens (3 ml) to the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The $19,526.44 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 16, 2024. This award is a child of a broader $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens, a pharmaceutical product used in the treatment of diabetes. The contract, valued at $35,223.56, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the Defense Logistics Agency (DLA) Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat diabetes. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order with a firm fixed price of $3,262.56 and a completion date of November 21, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens to the Defense Logistics Agency (DLA), a defense agency. The $15,788.20 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 29, 2024, with an ultimate completion date of August 30, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens, which are used to manage diabetes. The $4,547.82 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,517.78 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used to manage diabetes. The contract has an ultimate completion date of January 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens, a prescription medication used to treat type 2 diabetes. The $9,042.10 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of August 26, 2024 and does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a significant $999,999,999...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 mL capacity to the Defense Logistics Agency (DLA). The $1,871.54 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 30, 2023. The contract has an ultimate completion date of March 31, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pen 3 mL to the Defense Logistics Agency (DLA). The $57,987.46 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 3, 2023, with an ultimate completion date of April 4, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...